Past Events

Cell Culture 2016: 2nd- 4th February 2016

Off

CellBanner2016

Cell culture has matured to become the pivotal technology in biopharmaceutical research, development and production, and its use in this and other areas continues to expand rapidly.

This event will bring together leading researchers from many backgrounds in an informal setting, with plenty of opportunity for discussion and debate.

A late registration fee applies after December 20th 2015


THIS  EVENT  HAS  NOW  PASSED

WHO SHOULD ATTEND
This event is suited to anyone with an academic or professional interest in Cell Culture and related technologies; including researchers, senior scientists, postgraduate students, laboratory technicians, those who work in research and development of pharmaceuticals and technology.

This event has an open abstract session.  
Abstracts can be submitted on any subject related to cell culture
The Deadline for abstract submissions for oral presentation is November 10th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf

This event has  CPD accreditation

Talks Include: 
  • Building artificial nervous system tissues in vitro  

    Dr James Phillips, University College London, London, United Kingdom

  • 2D and 3D culture of neural stem cells: implications and future prospectives for neural stem cell transplantation research  

    Professor Peter Ponsaerts, University in Antwerp, Wilrijk, Antwerp, Belgium

  • A versatile miniature bioreactor platform for antibody production in fed-batch mammalian and microbial cell cultures

    Dr Farlan Veraitch, University College london, Department of Biochemical Engineering, London, United Kingdom

  • From Systems Engineering to Systems Biology: How mathematical models can help us improve cell culture processes.

    Dr Alexandros Kiparissides, Department of Biochemical Engineering, University College London, London, United Kingdom

  • 3D culture of osteoblasts in microbioreactors: critical role of dynamic fluid loading for cell morphogenesis

    Dr Brigitte Altmann, PhD, University Medical Center Freiburg, Center for Dental Medicine, Department of Prosthodontic Dentistry, Freiburg im Breisgau, Germany

  • Bioengineering human epidermal equivalents – what does really matters

    Dr Dusko Ilic MD PhD, Reader in Stem Cell Science, King’s College London Faculty of Life Sciences and Medicine, Division of Women’s Health, Women’s Health Academic Centre KHP, London, United Kingdom

  • Modelling the human nervous system in a dish

    Professor Patrizia Ferretti, UCL Institute of Child Health, London, United Kingdom

  • Using Cell-Culture -Based LDL Uptake Model for Screening PCSK9 inhibitors

    Dr Weiming Xu, London Biotech Ltd and Department of Molecular Biology and Biotechnology, University of Sheffield, Department of Molecular Biology and Biotechnology, Sheffield, United Kingdom

  • Integration of the ambr platform into mammalian process development

    Dr Steve Warr, Glaxo Smith Kline, Stevenage, United Kingdom

  • Precise engineering of biomimetic 3D environments

    Dr Alvaro Mata, School of Engineering and Materials Science, Queen Mary University of London, London, United Kingdom

  • Controlling Single Cell Geometry in 3D

    Dr Huabing Yin, University of Glasgow, Division of Biomedical Engineering, School of Engineering, Glasgow, United Kingdom

  • TBC

    Dr Hirofumi Matsui, University of Tsukuba, Tsukuba, Japan

  • Stem cell culture in a microfluidic device

    Dr Nicolas Szita, Biochemical Engineering, UCL, London, United Kingdom

  • 3D cultures of estrogen-responsive primary human breast epithelial cells offer novel insights into differential regulation of target genes in healthy vs. malignant cells

    Dr Afshin Raouf, Department of Immunology, University of Manitoba, Winnipeg, Canada

  • Applications of a thin layer angiogenesis assay

    Dr David Bishop-Bailey, Royal Veterinary College University of London, Royal College Street, London, United Kingdom

  • New bioengineering application with human pericytes for treatment of congenital heart disease

    Professor Paolo Roberto Madeddu, University of Bristol – School of Clinical Sciences, Bristol, United Kingdom

  • Biospray approaches for regenerative biology/medicine and theraputics

    Dr Suwan Jayasinghe, BioPhysics Group, University College London, Department of Mechanical Engineering, London, United Kingdom

  • Biomimetic poly(glycerol sebacate)-based elastomeric scaffolds for soft tissue engineering

    Dr Biqiong Chen, Department of Materials Science and Engineering, University of Sheffield, Sheffield, United Kingdom

  • Understanding the injury dynamics of kidney fibrosis in vitro through 3D co-culture system of kidney proximal tubular cells and fibroblast

    Dr. Bramasta Nugraha, ETH Zurich, Basel, Switzerland

  • A new 3D cell-based engineered intestinal in vitro model to explore intestinal absorption at earlier stage of drug delivery

    Dr Bruno Sarmento, Instituto de Engenharia Biomédica, Porto, Portugal

  • Accelerating strain development workflows with a novel single-use bioreactor system

    Dr. Barney Zoro, Sartorius Stedim Biotech, Royston, United Kingdom

Cell2016 Cell2016


Contact

Email:? enquiries [@] euroscicon.com

Phone:?(+44) 020 3807 3712

Abstract and Poster Presentations

All abstracts accepted for oral presentation are also automatically accepted for poster presentation

INSTRUCTIONS

Cancellation Policy

Join the conversation

Related past events

The2015VaccineSummit-Agenda

 


vaccines-2014-agenda


This is a closed event

Only participants who have registered are licensed to attend this event. This is for the protection and peace of mind of our speakers who are presenting unpublished work. We ask our participants not to share their screen with people who are not registered for the event and will fine those who do.

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: https://developer.twitter.com/en/portal/product